2nd Quarter - Report
TIBER CREEK GROUP for GILEAD SCIENCES, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to intellectual property protections for COVID-19 vaccines and treatments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
Health Issues HCR
Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to HIV.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| BRYANT HALL | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| BRYANT HALL | — |
| JONATHON JONES | — |
| COREY MALMGREN | — |
Budget/Appropriations BUD
Issues related to FY2024 appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LEFFINGWELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.